OTC Markets OTCPK - Delayed Quote USD

Fresenius SE & Co. KGaA (FSNUY)

11.67

-0.25

(-2.10%)

At close: 3:58:34 PM EDT

Q1 2025 Humacyte Inc Earnings Call

Q1 2025 Humacyte Inc Earnings Call

Thomson Reuters StreetEvents 15 hours ago

FRE.DE
Fresenius SE KGaA First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Fresenius SE KGaA ( ETR:FRE ) First Quarter 2025 Results Key Financial Results Revenue: €5.65b (up 5.6% from 1Q 2024...

Simply Wall St. 4 days ago

FSNUF

FSNUY
-2.10%
Fresenius SE & Co KGaA (FSNUF) Q1 2025 Earnings Call Highlights: Strong EPS Growth and ...

Fresenius SE & Co KGaA (FSNUF) reports a robust start to 2025 with double-digit EPS growth and strategic advancements in biopharma and nutrition sectors.

GuruFocus.com 6 days ago

FRE.DE
Fresenius: Q1 Earnings Snapshot

BAD HOMBURG, Germany (AP) — Fresenius Medical Care AG (FMS) on Tuesday reported first-quarter profit of $158.8 million. On a per-share basis, the Bad Homburg, Germany-based company said it had net income of 26 cents. Earnings, adjusted for non-recurring costs, were 44 cents per share.

Associated Press Finance 8 days ago

FME.DE

FRE.DE
Stocks to watch this week: Palantir, TSMC, Novo Nordisk and JD Wetherspoon

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 10 days ago

ARM

NXGPF

NXGPY
Retail investors who hold 37% of Fresenius SE & Co. KGaA (ETR:FRE) gained 5.9%, institutions profited as well

Key Insights Significant control over Fresenius SE KGaA by retail investors implies that the general public has more...

Simply Wall St. 13 days ago

FSNUF

FSNUY
-2.10%
Investors more bullish on Fresenius SE KGaA (ETR:FRE) this week as stock ascends 5.8%, despite earnings trending downwards over past year

If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost...

Simply Wall St. 29 days ago

FSNUF

FSNUY
-2.10%
Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year?

Here is how Concentra Group (CON) and Fresenius (FMS) have performed compared to their sector so far this year.

Zacks 30 days ago

CON

FRE.DE
Here's Why Fresenius (FMS) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks last month

FRE.DE
Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?

Delcath Systems (DCTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks last month

FRE.DE
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.

Zacks last month

PCRX

SRPT

EWTX
Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

PCRX and EWTX are in the spotlight this week following important regulatory and pipeline news.

Zacks last month

EWTX

PCRX

SRPT
PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Pacira BioSciences stock rises as it settles Exparel patent litigation with several generic players protecting the drug's exclusivity in the United States at least until 2030.

Zacks last month

FRE.DE

PCRX
Update: Pacira Biosciences Settles Patent Litigations Over Local Analgesic; Shares Rise Pre-bell

(Updates with stock price movement in the first paragraph and headline.) Pacira Biosciences (PCRX

PREMIUM
MT Newswires last month

FRE.DE
Pacira Biosciences Settles Patent Litigations Over Local Analgesic

Pacira Biosciences (PCRX) said Monday it settled the litigations with Fresenius Kabi USA, Jiangsu He

PREMIUM
MT Newswires last month

FRE.DE

600276.SS
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

NVRO

FRE.DE
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

FRE.DE
Fresenius SE KGaA Full Year 2024 Earnings: EPS Misses Expectations

Fresenius SE KGaA ( ETR:FRE ) Full Year 2024 Results Key Financial Results Revenue: €21.8b (up 3.6% from FY 2023). Net...

Simply Wall St. last month

FSNUF

FSNUY
-2.10%
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

TNDM

FRE.DE
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks last month

FRE.DE

Performance Overview

Return	FSNUY	DAX P (^GDAXI)
YTD	+34.14%	+18.17%
1-Year	+50.78%	+25.70%
3-Year	+37.64%	+67.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fresenius SE & Co. KGaA (FSNUY)

Q1 2025 Humacyte Inc Earnings Call

Fresenius SE KGaA First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Fresenius SE & Co KGaA (FSNUF) Q1 2025 Earnings Call Highlights: Strong EPS Growth and ...

Fresenius: Q1 Earnings Snapshot

Stocks to watch this week: Palantir, TSMC, Novo Nordisk and JD Wetherspoon

Retail investors who hold 37% of Fresenius SE & Co. KGaA (ETR:FRE) gained 5.9%, institutions profited as well

Investors more bullish on Fresenius SE KGaA (ETR:FRE) this week as stock ascends 5.8%, despite earnings trending downwards over past year

Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year?

Here's Why Fresenius (FMS) is a Strong Momentum Stock

Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

PCRX Stock Soars on Exparel Patent Settlement With Generic Players

Update: Pacira Biosciences Settles Patent Litigations Over Local Analgesic; Shares Rise Pre-bell

Pacira Biosciences Settles Patent Litigations Over Local Analgesic

Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Fresenius SE KGaA Full Year 2024 Earnings: EPS Misses Expectations

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term

Performance Overview